全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Epidemiological, Diagnostic, Therapeutic, and Outcome Profile of Pediatric Systemic Diseases in Chad

DOI: 10.4236/oalib.1114386, PP. 1-11

Subject Areas: Pediatrics

Keywords: Juvenile Idiopathic Arthritis, Pediatric Systemic Diseases, Acute Rheumatic Fever, Outcomes, Methotrexate, Sub-Saharan Africa, Chad

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: Pediatric systemic diseases are heterogeneous, potentially disabling, and under-reported in Sub-Saharan Africa. We aimed to describe their epidemiological, diagnostic, therapeutic, and outcome profile in a hospital setting in Chad. Methods: We conducted a retrospective descriptive study with a prospective component in the Rheumatology Unit between January 2020 and September 2024. Cases were identified using standard clinical and paraclinical criteria (ACR/EULAR where applicable). Demographic, clinical, laboratory, treatment, and outcome data (CHAQ, JADAS when available) were analyzed with SPSS 21.0. Results: Among 5000 patients seen during the study period, 111 fulfilled criteria for pediatric-onset systemic diseases (frequency 2.34%): juvenile idiopathic arthritis (JIA) 85 (76.6%) and connective tissue diseases 26 (23.4%) including acute rheumatic fever 7, juvenile Sjögren’s syndrome (primary/secondary) 15, dermatomyositis 2, systemic sclerosis 1, and systemic lupus erythematosus 1. Females accounted for 78/111 (70.3%). Mean age at disease onset was 11.21 years (range 2 - 16); mean diagnostic delay was 4.2 years (3 months - 32 years). JIA subtypes were: systemic 5 (including 1 MAS), RF-negative polyarticular 26, RF-positive polyarticular 14, oligoarticular 6, enthesitis-related arthritis 26, and undifferentiated 5. Acute anterior uveitis occurred in 13 cases. Management relied mainly on NSAIDs, corticosteroids, hydroxychloroquine, and methotrexate; biologics (etanercept) were used in 3 patients. Outcomes were generally favorable; three deaths were recorded (1 MAS, 1 infectious syndrome with dyspnea, 1 bedridden state). Conclusions: In this Chadian cohort, JIA predominated, whereas acute rheumatic fever was less frequent than historically reported. Conventional DMARDs remain the mainstay of therapy; access to biologics is limited. Diagnostic delays and severe complications underscore the need for earlier recognition, systematic follow-up, and im-proved access to advanced therapies.

Cite this paper

Garba, H. A. A. , Bah, A. , Bouchrane, R. , Lam, S. Y. , Ignazianki, R. , Hamid, H. A. A. , Niasse, M. , Saï and Diallo, D. (2025). Epidemiological, Diagnostic, Therapeutic, and Outcome Profile of Pediatric Systemic Diseases in Chad. Open Access Library Journal, 12, e14386. doi: http://dx.doi.org/10.4236/oalib.1114386.

References

[1]  Genereau, T., Lortholary, O., Sauvaget, F., Cohen, P., Jarrousse, B. and Guillevin, L. (1995) Complications infectieuses des maladies systémiques. Médecine et Maladies Infectieuses, 25, 976-984. https://doi.org/10.1016/s0399-077x(05)80312-9
[2]  Bouquier, J.J. and Brouchet, J. (1998) Existetil une limite d’age des patients dans l’exercice de la pédiatrie. Rapport Adopté Lors de la Session du Conseil National de l’Ordre des Médecins, 1-7.
[3]  Savadogo, M., Sanogo, T., Traoré, A., et al. (2023) Juvenile Idiopathic Arthritis in Burkina Faso: Diagnostic Challenges. Pan African Medical Journal, 46, Article 152.
[4]  Benromdhane, S., Ben Ali, F., Dammak, Y., et al. (2022) Functional Disability in Tunisian Children with JIA Using CHAQ. Ar-chives de Pédiatrie, 29, 187-193.
[5]  Consolaro, A., Giancane, G., Schiappa-pietra, B., et al. (2022) Updated Cutoffs for JADAS Scoring. Annals of the Rheumatic Diseases, 81, 263-271.
[6]  Ngahane, M.B., Njouom, R., Eone, D., et al. (2023) Pediatric Rheumatic Diseases in Cameroon. Health Sciences and Dis-eases, 24, 45-51.
[7]  Costa-Reis, P. and Sullivan, K.E. (2024) Imaging Role in JIA: Practical Updates. Frontiers in Medicine, 11, Article 1402681.
[8]  Barsaoui, S. (2005) Rhumatisme articulaire aigu chez l’enfant. EMC-Pédiatrie, 2, 243-255. https://doi.org/10.1016/j.emcped.2005.04.001
[9]  El Maghraoui, A. (2014) Arthrite juvénile idiopathique. La Presse Médicale, 43, 27-33. https://doi.org/10.1016/j.lpm.2013.01.073
[10]  Koné Paut, I. (2003) Ap-proches génétiques des pathologies inflammatoires de l’enfant. Revue du Rhu-matisme, 70, 517-520. https://doi.org/10.1016/s1169-8330(03)00191-1
[11]  Doualla, B.M., Ngan-deu, S.M., Luma, N.H. and Kemta, L.F. (2014) Les rhumatismes inflammatoires chroniques chez les patients de 0 à 20 ans à l’hôpital général de doua-la-cameroun. Health Sciences and Diseases, 15, 1-4.
[12]  Seck, N.B., Diadié, S., Fall, B.C., Diatta, B.A., Diallo, S., Diallo, M., et al. (2016) F14: La fièvre méditer-ranéenne familiale ou maladie périodique: Une observation à type de pannicu-lite. Annales de Dermatologie et de Vénéréologie, 143, S17. https://doi.org/10.1016/s0151-9638(16)30121-1
[13]  Chipeta, J., Njobvu, P., Wa-Somwe, S., Chintu, C., McGill, P.E. and Bucala, R. (2013) Clinical Patterns of Juvenile Idiopathic Arthritis in Zambia. Pediatric Rheumatology, 11, Article No. 33. https://doi.org/10.1186/1546-0096-11-33
[14]  Cotten, A., Mazingue, F., Pruvost, I. and Boutry, N. (2013) Arthrites juvéniles idiopathiques. In: Cot-ton, A., Ed., Imagerie Musculosquelettique: Pathologies Générales, Elsevier, 189-200. https://doi.org/10.1016/b978-2-294-71924-0.00005-x
[15]  Solau-Gervais, E., Robin, C., Gambert, C., Troller, S., Danner, S., Gombert, B., et al. (2010) Pré-valence et distribution des arthrites juvéniles idiopathiques dans une région de l’Ouest de la France. Revue du Rhumatisme, 77, 55-58. https://doi.org/10.1016/j.rhum.2009.04.009
[16]  Diomandé, M., Coulibaly, A., Kouakou, E., Yao, J., Kouakou, C., Gbané-Koné, M., et al. (2016) Profile of Juvenile Idiopathic Arthritis Observed in Abidjan (Cote d’ivoire): A Report about 17 Cases. British Journal of Medicine and Medical Research, 16, 1-6. https://doi.org/10.9734/bjmmr/2016/27043
[17]  Feliho, J.L.A. (2004) Ar-thrite chronique juvénile au Sénégal: Profils épidémiologique, clinique et as-pects évolutifs. Ph.D. Thesis, Cheikh Anta Diop University of Dakar (UCAD).
[18]  Abdwani, R., et al. (2014) Juvenile Idiopathic Arthritis in Oman: Clinical and Serological Profiles. Oman Medical Journal, 29, 119-123.
[19]  Fazza, A., et al. (2023) Assessment Tools in Juvenile Idiopathic Arthritis: A Narrative Update. Tunisie Médicale, 101, 537-543.
[20]  Dghaies, C., Guedri, R., Rebhi, M., Hrizi, H., Essaddam, L., Dahmouni, M., et al. (2022) 31 Oligoarticular Juvenile Idiopathic Arthritis in a Tunisian Pediatric Population. Rheumatology, 61, keac496. https://doi.org/10.1093/rheumatology/keac496.027
[21]  Bansal, N., Pasricha, C., Kumari, P., Jangra, S., Kaur, R. and Singh, R. (2023) A Compre-hensive Overview of Juvenile Idiopathic Arthritis: From Pathophysiology to Management. Autoimmunity Reviews, 22, Article ID: 103337. https://doi.org/10.1016/j.autrev.2023.103337
[22]  Alkwai, H., Alshammari, R., Abdwani, R., Almutairi, M., Alzyoud, R., Arkachaisri, T., et al. (2024) Quality Indicators for Care in Juvenile Idiopathic Arthritis. Journal of Rheumatic Dis-eases, 31, 223-229. https://doi.org/10.4078/jrd.2023.0071
[23]  Hong, J., Chen, Y., Su, Z., Chen, X., Lai, Y. and Yang, J. (2024) Causal Association of Juve-nile Idiopathic Arthritis or JIA-Associated Uveitis and Gut Microbiota: A Bidirec-tional Two-Sample Mendelian Randomisation Study. Frontiers in Immunology, 15, Article 1356414. https://doi.org/10.3389/fimmu.2024.1356414
[24]  Min, E.J., Kim, J.J., Lee, J.S., et al. (2024) Epidemiology of Juvenile Idiopathic Arthritis Using Big Data in Korea. Journal of Korean Medical Science, 39, e85.
[25]  Mosad, D.M., et al. (2025) African Guidelines for Diagnosis and Management of Polyarticular JIA (PAFLAR Initiative). Pediatric Rheumatology, 13, Article 1076.
[26]  Consolaro, A., Giancane, G., Ravelli, A., et al. (2021) Core Outcome Measures in Juvenile Idiopathic Arthritis: Update and Treat-to-Target Recommendations. Annals of the Rheumatic Diseases, 80, 159-166.
[27]  Otten, M.H., Prince, F.H., Ten Cate, R., et al. (2022) Long-Term Outcomes in Juvenile Idiopathic Arthritis: A Euro-pean Multicenter Registry Study. Rheumatology, 61, 2962-2970.
[28]  Onel, K.B., Horton, D.B., Lovell, D.J., Shenoi, S., Cuello, C.A., Angeles‐Han, S.T., et al. (2022) 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Tem-poromandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. Ar-thritis & Rheumatology, 74, 553-569. https://doi.org/10.1002/art.42037
[29]  Guzman, J., Petty, R.E., Rosenberg, A.M., et al. (2023) Outcomes in Juvenile Idiopathic Arthritis in the Era of Bio-logics: Results from a North American Registry. Journal of Rheumatology, 50, 130-139.
[30]  Palmisani, E., Pederzoli, S., Bovis, F., et al. (2023) Early Referral Improves Functional Outcomes in Juvenile Idiopathic Arthritis: An Italian Cohort Study. Clinical and Experimental Rheumatology, 41, 141-148.
[31]  Wallace, C.A., Onel, K., Huang, B., et al. (2024) Validation of the Juvenile Arthritis Dis-ease Activity Score in North American children. Pediatric Rheumatology, 22, Article 15.

Full-Text


Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133